- Home
- TELA vs SRZN Comparison
TELA vs SRZN Comparison
Compare TELA & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- SRZN
- Stock Information
- Founded
- TELA 2012
- SRZN 2015
- Country
- TELA United States
- SRZN United States
- Employees
- TELA N/A
- SRZN N/A
- Industry
- TELA Medical/Dental Instruments
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- TELA Health Care
- SRZN Health Care
- Exchange
- TELA Nasdaq
- SRZN Nasdaq
- Market Cap
- TELA 80.7M
- SRZN 72.8M
- IPO Year
- TELA 2019
- SRZN N/A
- Fundamental
- Price
- TELA $2.13
- SRZN $8.50
- Analyst Decision
- TELA Strong Buy
- SRZN Strong Buy
- Analyst Count
- TELA 4
- SRZN 2
- Target Price
- TELA $6.00
- SRZN $38.50
- AVG Volume (30 Days)
- TELA 58.1K
- SRZN 19.4K
- Earning Date
- TELA 08-11-2025
- SRZN 08-11-2025
- Dividend Yield
- TELA N/A
- SRZN N/A
- EPS Growth
- TELA N/A
- SRZN N/A
- EPS
- TELA N/A
- SRZN N/A
- Revenue
- TELA $71,217,000.00
- SRZN $11,638,000.00
- Revenue This Year
- TELA $26.67
- SRZN N/A
- Revenue Next Year
- TELA $22.63
- SRZN N/A
- P/E Ratio
- TELA N/A
- SRZN N/A
- Revenue Growth
- TELA 12.78
- SRZN N/A
- 52 Week Low
- TELA $0.86
- SRZN $5.90
- 52 Week High
- TELA $4.78
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- TELA 61.31
- SRZN 46.85
- Support Level
- TELA $1.95
- SRZN $8.31
- Resistance Level
- TELA $2.16
- SRZN $8.94
- Average True Range (ATR)
- TELA 0.16
- SRZN 0.50
- MACD
- TELA -0.01
- SRZN -0.02
- Stochastic Oscillator
- TELA 63.17
- SRZN 38.32
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).